Department of Ophthalmology and Visual Sciences

Opening a window to glaucoma

A metalloprotease enzyme plays an important role in retinal ganglion cell development, Vanderbilt researchers discovered; studying it and other family members may lead to the identification of novel targets for treating glaucoma.

The International Retinal Research Foundation Board’s Sandra Blackwood poses with Vanderbilt’s Paul Sternberg Jr., MD, left, and David Calkins, PhD.

Major commitment bolsters Vanderbilt’s retinal vision research efforts

A $10 million gift from the International Retinal Research Foundation will establish a center dedicated to retinal vision research at the Vanderbilt Eye Institute and a directorship to support a physician-scientist leader in the Department of Ophthalmology and Visual Sciences.

Calkins lands national award for research on blinding eye diseases

Vanderbilt’s David Calkins, PhD, has been selected by the Research to Prevent Blindness and Association of University Professors of Ophthalmology to receive the 2023 David F. Weeks Award for Outstanding Vision Research.

Sternberg to step down after two decades at Vanderbilt

Paul Sternberg Jr., MD, is stepping down from his role as chair of the Department of Ophthalmology and Visual Sciences and director of the Vanderbilt Eye Institute, effective June 30, 2023.

Mitochondria and retinal degeneration

Vanderbilt researchers have developed a new cellular model for exploring mitochondrial dysfunction in age-related macular degeneration, the leading cause of blindness in people over 65.

For young concussion patients, managing visual symptoms crucial

A policy statement from Vanderbilt and other institutions says it’s essential that pediatricians and other clinicians know how to screen, identify and initiate clinical management of visual symptoms after this common childhood injury.

1 2 3 4 9